TOXYLACT: a03 ac summary

The first professional lActological database in the word


The ATC A03AC group comprises synthetic antispasmodic drugs that are amide derivatives with tertiary amines, used mainly for functional gastrointestinal disorders and intestinal spasms, but with very limited lactation safety data and a precautionary approach in breastfeeding.medpedia.framar+2

Pharmacological class overview

Synthetic antispasmodics, amides with tertiary amines (ATC A03AC), are smooth‑muscle relaxants indicated for functional bowel disorders with cramping and abdominal pain.synapse.patsnap+1
They act predominantly on gastrointestinal smooth muscle with minimal central nervous system activity compared with classic anticholinergics, aiming to reduce spasm while limiting systemic side effects.apollopharmacy+1

Representatives and indications

According to the referenced ATC page, the principal substances in A03AC include dimethylaminopropionylphenothiazine (A03AC02), nicofetamide (A03AC04) and tiropramide (A03AC05).medbox.iiab+1
Tiropramide is marketed as an antispasmodic for abdominal pain and cramping associated with conditions such as irritable bowel syndrome and other gastrointestinal spasms.apollopharmacy+1

Toxicological profile

Typical adverse effects of A03AC antispasmodics reflect their smooth‑muscle relaxant and mild anticholinergic‑like actions and may include dry mouth, nausea, vomiting, constipation and rare hypersensitivity reactions.synapse.patsnap+1
Serious toxicity is uncommon at therapeutic doses, but caution is advised in patients with gastrointestinal stenosis, megacolon, severe circulatory failure or other conditions in which inhibition of motility could aggravate obstruction or ischemia.mims+1

Use during pregnancy and lactation

For tiropramide, available prescribing information advises against use in pregnancy and in nursing mothers unless clearly indicated and supervised, reflecting the absence of human data and theoretical risk to the infant.apollopharmacy+1
There is no robust published evidence on excretion of A03AC drugs into breast milk or on clinical outcomes in breastfed infants, so they should be avoided during breastfeeding whenever safer, better‑studied antispasmodic alternatives are available.sps+1

Lactation‑oriented recommendations

Given the paucity of lactation data and precautionary labelling, A03AC agents are generally not first‑line in breastfeeding women and should be reserved for situations where benefit clearly outweighs potential and unknown risks.infantrisk+3
If such treatment is considered unavoidable, it should be used at the lowest effective dose for the shortest possible duration, with close monitoring of the breastfed infant for sedation, feeding difficulties, gastrointestinal symptoms or allergic reactions, and with specialist toxicology‑lactation consultation.sps+2

Recent Posts

July 24

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

July 18

Abdominal Compartment Syndrome

While the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 14

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.